Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number:  000-28414

 

Urologix, Inc.

(Exact name of registrant as specified in its charter)

14405 21st Avenue North

Minneapolis, MN 55447

[phone]

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock

Series A Junior Participating Preferred Stock Purchase Rights

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

		Rule 12g-4(a)(1)	☒
		Rule 12g-4(a)(2)	☐
		Rule 12h-3(b)(1)(i)	☒
		Rule 12h-3(b)(1)(ii)	☐
		Rule 15d-6	☒

 

Approximate number of holders of record as of the certification or notice date:    214              

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Urologix, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

 

DATE:  July 10, 2015	By:	/s/  Scott M. Madson
		Scott M. Madson Chief Financial Officer